These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 14647266
1. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts. Theilgaard-Mönch K, Raaschou-Jensen K, Schjødt K, Heilmann C, Vindeløv L, Jacobsen N, Dickmeiss E. Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266 [Abstract] [Full Text] [Related]
2. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Theilgaard-Mönch K, Raaschou-Jensen K, Andersen H, Russell CA, Vindeløv L, Jacobsen N, Dickmeiss E. Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255 [Abstract] [Full Text] [Related]
3. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Ho AD, Young D, Maruyama M, Corringham RE, Mason JR, Thompson P, Grenier K, Law P, Terstappen LW, Lane T. Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228 [Abstract] [Full Text] [Related]
4. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Theilgaard-Mönch K, Raaschou-Jensen K, Palm H, Schjødt K, Heilmann C, Vindeløv L, Jacobsen N, Dickmeiss E. Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619 [Abstract] [Full Text] [Related]
7. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R. Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278 [Abstract] [Full Text] [Related]
8. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Singhal S, Powles R, Kulkarni S, Treleaven J, Sirohi B, Millar B, Shepherd V, Saso R, Rowland A, Long S, Cabral S, Horton C, Mehta J. Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626 [Abstract] [Full Text] [Related]
9. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants. Kwekkeboom J, Buurman DE, Ploemacher RE, Baars JW, Loos HA, Slaper-Cortenbach IC. Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656 [Abstract] [Full Text] [Related]
10. Expansion of HPCs from cord blood in a novel 3D matrix. Ehring B, Biber K, Upton TM, Plosky D, Pykett M, Rosenzweig M. Cytotherapy; 2003 May; 5(6):490-9. PubMed ID: 14660045 [Abstract] [Full Text] [Related]
11. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors. Yang SH, Wang TF, Tsai HH, Lin TY, Wen SH, Chen SH. Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055 [Abstract] [Full Text] [Related]
12. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen. Menéndez P, Caballero MD, Prosper F, Del Cañizo MC, Pérez-Simón JA, Mateos MV, Nieto MJ, Corral M, Romero M, García-Conde J, Montalbán MA, San Miguel JF, Orfao A. Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673 [Abstract] [Full Text] [Related]
13. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation. Chang Q, Harvey K, Akard L, Thompson J, Dugan MJ, English D, Jansen J. Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064 [Abstract] [Full Text] [Related]
14. Clinical impact of a new automated system employed for peripheral blood stem cell collection. Del Fante C, Perotti C, Viarengo G, Bellotti L, Parisi C, Marchesi A, Tinelli C, Salvaneschi L. J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939 [Abstract] [Full Text] [Related]
15. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor. Lorenzon D, Mazzucato M, Abbruzzese L, Cilli M, De Angeli S, Degan M, Mambrini G, Piccardi F, Rupolo M, Michieli M, De Marco L, Gattei V, Astori G. Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263 [Abstract] [Full Text] [Related]
16. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation]. Klabusay M, Lysák D, Hrabcáková V, Navrátil M, Coupek P, Mayer J. Cas Lek Cesk; 2008 May; 147(6):319-24. PubMed ID: 18724529 [Abstract] [Full Text] [Related]
17. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression. Villaron EM, Almeida J, Lopez-Holgado N, Sanchez-Guijo FM, Alberca M, Blanco B, Sanchez-Abarca LI, Lopez O, Perez-Simon JA, San Miguel JF, del Cañizo MC. Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836 [Abstract] [Full Text] [Related]